Article thumbnail

Genetic vaccination for reestablishing T-cell tolerance in type 1 diabetes

By Mark C Johnson, Bo Wang and Roland Tisch

Abstract

Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease resulting in the destruction of the insulin-secreting β cells. Currently, there is no established clinical approach to effectively suppress long-term the diabetogenic response. Genetic-based vaccination offers a general strategy to reestablish β cell-specific tolerance within the T cell compartment. The transfer of genes encoding β cell autoantigens, anti-inflammatory cytokines and/or immunomodulatory proteins has proven to be effective at preventing and suppressing the diabetogenic response in animal models of T1D. The current review will discuss genetic approaches to prevent and treat T1D with an emphasis on plasmid DNA- and adeno-associated virus-based vaccines

Topics: Review
Publisher: Landes Bioscience
OAI identifier: oai:pubmedcentral.nih.gov:3062240
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles